CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS;ALIANZA ESPAÑOLA DE FAMILIAS DE VON HIPPEL-LINDAU-VHL
发明人:
Luisa María BOTELLA CUBELLS,Virginia ALBIÑANA DÍAZ,Karina VILLAR GOMEZ-DE LAS HERAS
申请号：
US16636959
公开号：
US20200323798A1
申请日:
2018.08.06
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The invention relates to the use of a selective β2 adrenergic receptor antagonist for treating and preventing a tumor in a patient with von Hippel-Lindau syndrome. In particular, the invention relates to the use of an alkanolamine derivative or a pharmaceutically acceptable acid-addition salt thereof for treating and preventing a hemangioblastoma in VHL syndrome patients.
